27 July 2022 in Journal of microbiology, epidemiology and immunobiology
Background. The incidence of COVID-19 novel coronavirus infection has a wave-like pattern with surges in new cases followed by declines. Viral mutations, changes in viral properties, and new strains continue to emerge and are regularly reported.The aim of the study is to present a comparative analysis of clinical and epidemiological characteristics of hospitalized patients with COVID-19 during different periods of the coronavirus infection pandemic in Moscow.Materials and methods. A two-center, retrospective observational epidemiological study was performed using medical records of patients hospitalized with the confirmed diagnosis of COVID-19 in Moscow from March 2020 to March 2022 (34,354 patients).Results. Within 2 years of the pandemic, there were significant differences in the age structure of hospitalized patients. During the early months (March–June 2020) of the pandemic, age groups of 18–45 and 46–65 yearolds accounted for higher percentages of hospitalizations. Later on (July 2020 – February 2021), the proportion of older age groups demonstrated an upward trend. From spring 2021 (the emergence of the SARS-CoV-2 delta strain) to March 2022 (dominance of the omicron strain), the proportion of hospitalized working-age adults increased once again.The proportion of severe and critically severe cases among the patients hospitalized during different periods remained at steady levels: 7.7% (6.6–8.8%) and 5.5% (4.4–6.6%), respectively. The highest death rates were observed during the delta strain surge, while the lowest death rates were reported for the omicron strain. Throughout the pandemic, the older age and chronic diseases remained risk factors contributing to the severity of the disease and adverse outcomes.Conclusion. The emergence of new variants of SARS-CoV-2 causing a shift of the need for hospitalization towards younger age groups, the persistent high rates of severe cases and death rates among people of retirement age are pressing for the unfailing readiness for implementing preventive and epidemic control measures focusing on the above groups of population.
30 December 2018 in Journal Infectology
The goal of study was the epidemiological substantiationof optimization measures of a vaccinal prevention of whooping cough in the Russian Federation. Materials and methods. The retrospective descriptive epidemiological research has been conducted by analysis of the official statistical data on the whooping cough case rate (form No. 2) in 2005–2017 in the Russian Federation, as well as the data about preventive whooping cough inoculations (forms No. 5, No. 6) in 2005–2017 and about epidemic outbreakes in 2017 (form No. 23-17). The assessment of an economic damage from whooping cough in 2005-2017 has been carried out. Results. The following adverse characteristics of a modern epidemiological situation on whooping cough in Russia are shown: long-term recurrence of epidemic process, tendency of rising of a case rate of children of 0-2 years; high percentage of children of preschool and school age among whooping cough cases; prevalence among the patients with whooping cough of the children who have been vaccinated against this infection previously, epidemic outbreakes in children’s collectives, the stability of a case rate of teenagers and adults with prevalence of the mild and the erased clinical forms of this infection. The risks due to weaknesses of the whooping cough vaccinal prevention are noted: the insufficient immunization coverage owing to falce contraindications and refusals of parents of vaccinations of children, noncompliance with terms and intervals between inoculations, lack of domestic vaccine for revaccination of children at the age of 5 years and older. Conclusion. It is necessary to introduce in the national vaccination schedule a preschool booster dose for children at the age of 6 and adolescents at 14 years with the combined reduced antigen content tetanus–diphtheria and acellular pertussis vaccines as well as the inoculations of this vaccine according to epidemiological indications to health workers, employees of educational institutions. A revaccination against whooping cough is recommended as “cocoon” for the persons contacting to not vaccinated child under 1 year of age.
16 January 2020 in Epidemiology and Vaccinal Prevention
Subject.Varicella continues to be a common childhood infection, but thereof danger is underestimated in our country and around the world. About 800 thousand people get sick every year in the Russian Federation, half of whom are children 3–6 years old. In addition, for economic damage from infectious and parasitic diseases, varicella in the Russian Federation occupies 2–3 place for eleven years.Objectives.To substantiate the need to introduce varicella vaccine into the National immunization schedule of the Russian Federation based on the experience of introducing vaccination into regional schedules.Materials and Methods.The descriptive epidemiological method was used – a retrospective epidemiological analysis. Materials for the study were: Form № 2 «Information about infectious and parasitic diseases» for 2007–2017; State reports «On the state of sanitary and epidemiological welfare of the population in the Russian Federation» for 2016, 2017; scientific publications on the studied issue in Russian and English. The program «Microsoft Excel» was used to process the research data. Results. In regions in which varicella vaccination is introduced into regional immunization schedules, the incidence of infection tends to decrease at least to 3,1%, in contrast to regions where it is not introduced and there the incidence is increasing every year to 2,8%. The experience of using mass vaccination in other countries has shown its effectiveness, what is observed by decrease the incidence to a sporadic level.Discussion.The incidence of varicella in 2017 by region of the Russian Federation, where vaccination is included into regional immunization schedule, is 75% lower than the national average. Analysis of varicella vaccination introduction experience in other countries clearly shows that this method of combating varicella can significantly reduce the incidence, as well as reduce economic damage (US – 0.9 billion dollars, Japan – 36.2 billion yen).Conclusion.The vaccine prophylaxis of varicella clearly shows that this method of combating this infection can significantly reduce the incidence and at times reduce the economic damage from infection. With this in mind, the need to consider the inclusion of varicella vaccination in the Russian Federation National Schedule of Vaccinations.
20 February 2017 in Epidemiology and Vaccinal Prevention
Грипп и ОРВИ продолжают оставаться основной нозологической формой в структуре всех инфекционных заболеваний. Особенно опасен грипп для беременных. Цель: оценить отношение беременных и медицинских работников к вакцинации против гриппа. Материалы и методы: форма № 5, формы статистического учета №1-грипп раздел 1, информация с официального сайта ФГБУ «НИИ гриппа» Минздрава РФ; информационно-аналитические справки Министерства здравоохранения РФ. Было проанкетировано на различных территориях РФ 1126 беременных на разных сроках беременности и 447 медработников. Статистическая обработка проводилась с использованием программ Microsoft Excel 2010 и IBM SPSS Statistics 20.0. Результаты и обсуждение. Среди опрошенных беременных планировали или уже вакцинировались против гриппа лишь 8% женщин, Наиболее частые причины отказа от вакцинации против гриппа во время беременности: сомнение в безопасности. О внесении в Национальный календарь профилактических прививвок вакцинации против гриппа беременных знали лишь 25% опрошенных. 73% опрошенных медицинских работников не рекомендовали беременным вакцинацию против гриппа, в связи с тем, что считают нежелательным вмешательство в иммунитет беременной, 33% сомневаются в безопасности вакцинации, 13% вообще не знают о возможности вакцинации против гриппа беременных, 6% имеют личный негативный опыт вакцинации против гриппа, а 4% не видят необходимости в вакцинации от гриппа. Заключение: полученные материалы свидетельствуют о необходимости совершенствования обучения медицинских работников по вакцинопрофилактике инфекционных болезней, включая и вакцинацию против гриппа беременных, а также проводить широкую и активную информационно-пропагандистскую работу с населением, привлекая средства массовой информации.
15 December 2022 in Problems of Social Hygiene, Public Health and History of Medicine
The pandemic of new coronavirus infection continues affecting many areas of public life. Against the background of arising variations, occur changes in people's psychological condition and in belief systems and attitudes to many fields of human knowledge, including medicine. The purpose of the study is to evaluate potential effect of COVID-19 pandemic on developing civil liability of the population of the Russian Federation regarding anti-epidemic activities to fight infectious diseases.Materials and methods. The special anonymous on-line questionnaire was developed and placed on popular social platforms in open access. The questionnaire included two parts and contained 27 closed alternative questions with only one alternative to answer. The respondents included persons older than 18 years agreed to participate in survey. The data gathering provided for three subsequent stages. The final sampling consisted of 1350 respondents, out of them 1230 were citizen of the Russian Federation and 120 representatives of the near abroad.Results and discussion. More than 65% of respondents confirmed positive changes of one's attitude to sanitary hygienic activities to better sense. Among them, 63.3% began to wash hands more regularly and 62.2% began to apply hand antiseptic more often. The comparing of study results by individual characteristics revealed a significant effect of primary hygienic status of respondents on magnitude of fixed changes. It is established that during 5 months the population readiness to be vaccinated by one of the registered national vaccines was increasing and level of uncertainty was decreasing. Among respondents 73.5% marked increasing of individual responsibility of citizens for hygienic practices.Conclusion. The study demonstrated significant improvement of population attitude to sanitary hygienic practices after onset of pandemic. The greatest changes are observed in individuals with initially sufficient levels of hygienic commitment. On the basis of study results, the conclusion can be made about significant increasing of civil liability of the population of the Russian Federation for hygienic practices, especially against the background of COVID-19 pandemic.
14 January 2025 in Epidemiology and Vaccinal Prevention
Relevance. A distinctive feature of the influenza is the risk of severe complications, including cardiovascular (myocarditis or pericarditis) and nervous (encephalitis, meningoencephalitis and arachnoiditis) systems. Vaccination against influenza can significantly reduce the risk of disease, including complications and deaths.The aim of our study was to evaluate the epidemiological effectiveness of a quadrivalent inactivated split influenza vaccine in the 2023 –2024 season.Materials and methods. The study investigated the effectiveness of the tetravalent inactivated split vaccine Ultrix Quadri®. Vaccination data were collected in the regions of the Russian Federation as of January 1, 2024, in which a statistically significant amount of Ultrix Quadri® vaccine was used. The work was carried out using methods of variational statistics. The indicators of relative and attributive risks were evaluated, the Cochrane-Mantel-Hensel approach was applied, taking into account the assessment of heterogeneity of the results, and the effectiveness of the vaccine was evaluated.Results. The study showed that the risk of getting the flu among those vaccinated with Ultrix Quadri® vaccine was 122 (88-170) times lower than in those not vaccinated, which indicates the high epidemiological effectiveness of the vaccine. Cases of influenza among those vaccinated were observed in December 2023 - January 2024, that is, at the beginning of the epidemic season, during the period of the greatest rise in morbidity. At the same time, in absolute terms, their number was minimal. (414 cases out of 9.7 million vaccinated). From February to June 2024, the incidence of influenza among those vaccinated with the studied vaccine (with the exception of isolated cases) was not recorded.Conclusion. The conducted study demonstrated the high real epidemiological effectiveness of the Ultrix Quadri® vaccine during the epidemic season of influenza and ORI 2023/2024.